We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Exforge Deal ‘More Pernicious’ Than Actavis, Court Told

Law360 (November 8, 2018, 6:03 PM EST) -- An alleged deal between Novartis and Par Pharmaceutical to delay a generic of hypertension medication Exforge is illegal because it was far more anticompetitive than what the U.S. Supreme Court dealt with in its landmark Actavis decision, Walgreens and Kroger...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.